Inhalation scintigraphy with iodine-123-labeled interferon gamma-1b: Pulmonary deposition and dose escalation study in healthy volunteers

Journal of Nuclear Medicine

Volumn 38, Issue 9, 1997, Pages 1475-1481

  Virgolini, Irene ^a   Kurtaran, Amir ^b   Leimer, Maria ^b   Smith Jones, Peter ^b   Agis, Hermine ^b   Angelberger, Peter ^b   Kletter, Kurt ^b   Valent, Peter ^b   Linkesch, Werner ^b   Eichler, Hans Georg ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

Dose escalation study; Dosimetry; Healthy volunteers; Inhalation scintigraphy; Iodine 123 IFNg

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON I 123; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DOSIMETRY; DRUG BLOOD LEVEL; DRUG HALF LIFE; FEMALE; HUMAN; HUMAN EXPERIMENT; INHALATIONAL DRUG ADMINISTRATION; LUNG SCINTISCANNING; MALE; NEBULIZATION; NORMAL HUMAN; PRIORITY JOURNAL; WHOLE BODY SCINTISCANNING;

ADMINISTRATION, INHALATION; FEMALE; HALF-LIFE; HUMANS; INTERFERON-GAMMA, RECOMBINANT; IODINE RADIOISOTOPES; LUNG; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; REFERENCE VALUES;

EID: 0030930259     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Murray HW. Interferon-gamma, the activated macrophage and host defense against microbial challenge. Ann Intern Med 1988;108:595-608.
2. Black CM, Catterall JR, Remington JS. In vivo and in vitro activation of alveolar macrophages by recombinant interferon-γ. J Immunol 1987;138:491-495.
3. Nathan CF, Murray HW, Wiebe ME, Rubin BY. Identification of interferon-γ as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med 1983;158:870-889.
4. Murray HW, Gellene RA, Libby DM, et al. Activation of tissue macrophages from AIDS patients: in vitro response of AIDS alveolar macrophages to lymphookines and interferon-γ. J Immunol 1985;135:2374-2377.
5. Iwamoto I, Nakajima H, Endo H, Yoshida S. Interferon gamma regulates antigen-induced eosinophil recruitment into the mouse airways by inhibiting the infiltration of CD4+ T cells. J Exp Med 1993;177:573-576.
6. The International Chronic Granulomatous Disease Cooperative Study Group. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med 1991;324:509-516.
7. Jaffe HA, Buhl R, Mastrangeii A, et al. Organ specific cytokine therapy: local activation of mononuclear phagocytes by delivery of an aerosol of recombinant interferon-γ to the human lung. J Clin Invest 1991;88:297-302.
8. Halme M. Inhaled gamma-interferon gamma in humans: pharmacokinetics and effects on alveolar macrophages and blood cells [Abstract]. Am Rev Respir Dis 1992;145: A591.
9. Nakajima H, Iwamoto I, Yoshida S. Aerosolized recombinant interferon-gamma prevents antigen-induced eosinophil recruitment in mouse trachea. Am Rev Respir Dis 1993;148:1102-1104.
10. Heicappel R, Ackermann R. Rationale for immunotherapy of renal cell carcinoma. Urol Res 1990;18:357-372.
11. Queseda JR, Swanson DA, Trindade AV. Renal cell carcinoma: antitumor effects of leukocyte interferon. Cancer Res 1983;43:940-947.
12. Ernstoff MS, Nair S, Bahnson RR, et al. A Phase I trial of sequential administration recombinant DNA produced interferons: combination recombinant interferon-gamma and recombinant interferon-alpha in patients with metastatic renal cell carcinoma. J Clin Oncul 1989;8:1637-1649.
13. Aulitzky W, Gastl G, Aulitzky WE, et al. Successful treatment of metastatic renal cell carcinoma with a biologically active dose of recombinant interferon-gamma. J Clin Oncol 1989;7:1875-1884.
14. Pessina GP, Paulesu L, Corradeschi F, et al. Pulmonary catabolism of interferon-gamma evaluated by lung perfusion in both normal and smoke-exposed rats. J Interferon Cytokine Res 1995;15:225-230.
15. Jaffe HA, Buhl R, Mastrangeli A, et al. Aerosol delivery of recombinant interferon-γ to the lung: demonstration of upregulation of interferon-γ inducible genes in alveolar macrophages [Abstract]. J Interferon Res 1990;10(Suppl. 1):S12.
16. Martin RJ, Boguniewicz M, Henson JE, et al. The effects of inhaled interferon gamma in normal human airways. Am Rev Respir Dis 1993;148:1677-1682.
17. Virgolini I, Angelberger P, Raderer M, et al. Vasoactive intestinal peptide receptor imaging in the localization of intestinal adenocarcinomas and endocrine tumors. N Engl J Med 1994;331:1116-1121.
18. Virgolini I, Sillaber C, Majdic O, et al. Characterization of prostaglandin binding sites expressed on human basophils. J Biol Chem 1992;267:12700-12708.
19. Valent P, Bevec D, Maurer D, et al. Interleukin 4 promotes expression of mast cell ICAM-1 antigen. Proc Natl Acad Sci USA 1991;88:3339-3342.
20. Thomas SHL, O'Doherty MJ, Page CL, Nuan TO. Variability in the measurement of nebulized aerosol deposition in man. Clin Sci 1991;81:767-775.
21. Macey DJ, Marshall R. Absolute quantification of radiotracer uptake in the lungs using a gamma camera. J Nucl Med 1982;23:731-735.
22. Smaldone GC, O'Riordan TG. Aerosol deposition and clearance. In: Wagner H Jr, Szabo Z, Buchanan J, eds. The principles of nuclear medicine, 2nd ed. Philadelphia: W. B. Saunders Company 1995;895-905.
23. Loevinger R, Merman M. A revised schema for calculating the absorbed dose from biologically distributed radionuclides, MIRD pamphlet no. 1, revised. New York: Society of Nuclear Medicine; 1976.
24. Synder WS, Ford MR, Warner GG, Watson SB. "S" absorbed dose per unit cumulated activity for selected radionuclides and organs, MIRD pamphlet no. 11. New York: Society of Nuclear Medicine; 1975.
25. IRCP. Human respiratory tract: model for radiological protection, IRCP publication no. 66. (1-3). Ann ICRP 1994.
26. Atkins HL, Weber DA, Susskind H, Thomas SR. MIRD dose estimate report no. 16. Radiation absorbed dose from technetium-99m diethylenetriamineopentaacetic acid aerosol. J Nucl Med 1992;33:1717-1719.
27. Sataki I, Tari K, Nakagomi K, Ozawa K. Feasibility and pharmacokinetics of continuous subcutaneous infusion of low-dose interferon-gamma: a pilot study. Jpn J Clin Oncol 1993;23:356-362.
28. Ferretti PP, Annibale V, Gafa SI, et al. Pulmonary deposition of aerosolized pentamidine using a new nebulizer: efficiency measurements in vitro and in vivo. Eur J Nucl Med 1994;21:399-406.